UBS Group’s Bionano Genomics, Inc. Warrant BNGOW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,210
| Closed | -$113 | – | 10190 |
|
|
2023
Q1 | $113 | Sell |
1,210
-15,606
| -93% | -$2.94K | ﹤0.01% | 9221 |
|
|
2022
Q4 | $1.68K | Sell |
16,816
-3,050
| -15% | -$776 | ﹤0.01% | 9812 |
|
|
2022
Q3 | $5K | Buy |
19,866
+15,539
| +359% | +$5.4K | ﹤0.01% | 9276 |
|
|
2022
Q2 | $1K | Buy |
4,327
+4,081
| +1,659% | +$1.65K | ﹤0.01% | 10103 |
|
|
2022
Q1 | $0 | Sell |
246
-7,094
| -97% | -$5.77K | ﹤0.01% | 11240 |
|
|
2021
Q4 | $8K | Buy |
+7,340
| New | +$12.5K | ﹤0.01% | 9089 |
|
|
2021
Q1 | – | Sell |
-370
| Closed | -$1K | – | 9657 |
|
|
2020
Q4 | $1K | Buy |
370
+314
| +561% | +$83 | ﹤0.01% | 8279 |
|
|
2020
Q3 | $0 | Sell |
56
-29,313
| -100% | -$5.91K | ﹤0.01% | 8567 |
|
|
2020
Q2 | $4K | Buy |
29,369
+23,807
| +428% | +$2.58K | ﹤0.01% | 7493 |
|
|
2020
Q1 | $1K | Sell |
5,562
-1,738
| -24% | -$415 | ﹤0.01% | 7839 |
|
|
2019
Q4 | $2K | Buy |
+7,300
| New | +$1.23K | ﹤0.01% | 7878 |
|
|
2019
Q3 | – | Sell |
-1,051
| Closed | -$1K | – | 8360 |
|
|
2019
Q2 | $1K | Hold |
1,051
| – | – | ﹤0.01% | 7758 |
|
|
2019
Q1 | $1K | Sell |
1,051
-99
| -9% | -$157 | ﹤0.01% | 7582 |
|
|
2018
Q4 | $1K | Buy |
+1,150
| New | +$2.84K | ﹤0.01% | 7934 |
|
Other funds holding BNGOW
UBS Group's BNGOW Position: Q2 2023 in Review
UBS Group sold out of Bionano Genomics, Inc. Warrant (BNGOW) in Q2 2023, closing a stake of 1,210 shares — an estimated $113 sold.
UBS Group first reported a position in BNGOW in Q4 2018 and held it in 14 quarters. The position peaked at $8K in Q4 2021. 2 funds tracked by Wall St. Rank hold BNGOW as of Q2 2023.
- UBS Group reported no remaining Bionano Genomics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
- UBS Group sold 1,210 Bionano Genomics, Inc. Warrant shares in Q2 2023, an estimated $113.
- UBS Group first reported a position in Bionano Genomics, Inc. Warrant in Q4 2018 and held it in 14 quarters.
- UBS Group's Bionano Genomics, Inc. Warrant position peaked at $8K in Q4 2021.
- 2 funds tracked by Wall St. Rank held Bionano Genomics, Inc. Warrant as of Q2 2023.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.